If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPorvair Regulatory News (PRV)

Share Price Information for Porvair (PRV)

Share Price is delayed by 15 minutes
Get Live Data
820.00    0.00 (0.00%)
Bid:
800.00
Ask:
838.00
Spread: 38.00 (4.75%)
Market Cap: £377.99m
PRV Live PriceLast checked at - London Stock Exchange

Intraday Porvair Share Chart

Trading Update

15 Sep 2015 07:00

RNS Number : 0229Z
Porvair PLC
15 September 2015
 

For immediate release

15 September 2015

 

 

 

Porvair plc ("Porvair")

 

Trading update

 

 

Porvair plc ("Porvair"), the specialist filtration and environmental technology group today issues the following trading update for the nine months to 31 August 2015.

 

Porvair continued to trade well. Underlying revenues (1) for the nine months to 31 August 2015 were 9% higher than in the first nine months of 2014.

 

As previously reported, there will not be a recurrence in 2015 of the unusually high revenues recognised from several large projects in 2014. Total revenues are therefore 9% lower than the prior year. Profit before tax is in line with management's expectation.

 

Underlying revenues in the Microfiltration division were 13% ahead of the prior period. Progress towards commissioning of the large projects (gasification projects for POSCO, Reliance and CNOOC and a UK nuclear remediation contract) continued as anticipated. The Metals Filtration division traded in line with management's expectations, 1% ahead of the prior period (in constant currency: 7% below the prior period). Order books for the final quarter are satisfactory.

 

New plants in the UK and USA opened in the first half. The expansion of the China facility is on schedule and to budget. A new facility in Ashland, VA, has been leased and is expected to be occupied by around the end of the first quarter 2016.

 

At 31 August 2015, the Group had a net cash of £9m (31 August 2014: net debt of £0.3m).

 

Note (1) Underlying revenue: Revenue excluding the impact of large projects.

 

For further information, please contact:

 

Porvair plc

01553 765 500

Ben Stocks, Chief Executive

Chris Tyler, Group Finance Director

Buchanan

0207 466 5000

Charles Ryland / Stephanie Watson

 

 

 

 

 

Notes to Editors

 

Porvair is a group of specialist filtration and environmental technology businesses. Its businesses design and manufacture a range of bespoke consumable filtration products that are used in a range of niche filtration markets. Its principal markets are aviation, energy and industrial process, environmental laboratories and non-ferrous metals.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTQZLFFEKFZBBF
Date   Source Headline
23rd Nov 20204:36 pmRNSPrice Monitoring Extension
11th Nov 20201:17 pmRNSHolding(s) in Company
9th Nov 20207:00 amRNSDirectorate Change
23rd Oct 20204:40 pmRNSSecond Price Monitoring Extn
23rd Oct 20204:35 pmRNSPrice Monitoring Extension
7th Oct 20204:35 pmRNSPrice Monitoring Extension
28th Sep 20204:41 pmRNSSecond Price Monitoring Extn
28th Sep 20204:35 pmRNSPrice Monitoring Extension
22nd Sep 20207:00 amRNSNine months trading update
18th Sep 20203:58 pmRNSChange of auditor
2nd Sep 20202:09 pmRNSHolding(s) in Company
19th Aug 20204:03 pmRNSDirector/PDMR Shareholding
10th Aug 20204:40 pmRNSSecond Price Monitoring Extn
10th Aug 20204:36 pmRNSPrice Monitoring Extension
31st Jul 20207:00 amRNSTotal Voting Rights
3rd Jul 20204:41 pmRNSSecond Price Monitoring Extn
3rd Jul 20204:36 pmRNSPrice Monitoring Extension
29th Jun 20207:00 amRNSHalf Year Results 2020
25th Jun 20204:52 pmRNSDirector/PDMR Shareholding
2nd Jun 20204:36 pmRNSPrice Monitoring Extension
20th May 20204:36 pmRNSPrice Monitoring Extension
19th May 20204:36 pmRNSPrice Monitoring Extension
23rd Apr 20209:27 amRNSPublication of Articles of Association
21st Apr 20201:59 pmRNSAGM resolutions and Board changes
8th Apr 20204:03 pmRNSBlock listing six monthly return
8th Apr 20207:00 amRNSTrading Update and Covid-19 Statement
30th Mar 20204:36 pmRNSPrice Monitoring Extension
30th Mar 202012:08 pmRNSSecond Price Monitoring Extn
30th Mar 202012:02 pmRNSPrice Monitoring Extension
26th Mar 202012:07 pmRNSSecond Price Monitoring Extn
26th Mar 202012:02 pmRNSPrice Monitoring Extension
26th Mar 20207:00 amRNSAnnual General Meeting 2020 – Change of Venue
23rd Mar 20204:43 pmRNSSecond Price Monitoring Extn
23rd Mar 20204:38 pmRNSPrice Monitoring Extension
20th Mar 20204:43 pmRNSSecond Price Monitoring Extn
20th Mar 20204:37 pmRNSPrice Monitoring Extension
19th Mar 20204:43 pmRNSSecond Price Monitoring Extn
19th Mar 20204:39 pmRNSPrice Monitoring Extension
18th Mar 202012:08 pmRNSSecond Price Monitoring Extn
18th Mar 202012:03 pmRNSPrice Monitoring Extension
17th Mar 20204:41 pmRNSSecond Price Monitoring Extn
17th Mar 20204:38 pmRNSPrice Monitoring Extension
13th Mar 20204:42 pmRNSSecond Price Monitoring Extn
13th Mar 20204:36 pmRNSPrice Monitoring Extension
6th Mar 202010:20 amRNSHolding(s) in Company
18th Feb 202012:07 pmRNSSecond Price Monitoring Extn
18th Feb 202012:02 pmRNSPrice Monitoring Extension
18th Feb 20207:00 amRNSDirector/PDMR Shareholding
11th Feb 20203:15 pmRNSPDMR Shareholding Grant of Options
3rd Feb 20207:00 amRNSPreliminary Results and Board Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.